Biomeme

About:

Biomeme is a real-time PCR thermocycler that attaches to iPhone 5s and enables DNA diagnostics and real-time disease surveillance.

Website: https://biomeme.com

Twitter/X: BiomemeInc

Top Investors: Dreamit Ventures, Future Communities Capital, Robin Hood Ventures, ic@3401

Description:

Biomeme is a real-time PCR thermocycler that attaches to iPhone 5s and enables DNA diagnostics and real-time disease surveillance. The system includes a docking station for real-time qPCR, a mobile app to control the system and analyze results, and targeted test kits for preparing samples and identifying pathogens or diseases by their specific DNA or RNA signatures. The system enables users to isolate DNA, analyze it using lab technology, and manage results in the cloud. It facilitates mobile testing at the point-of-need for healthcare, agriculture, vector surveillance, veterinary medicine, environmental monitoring, and education and citizen science. Biomeme was developed by Biomeme Inc., a Philadelphia-based company co-founded by Max Perelman, Jesse vanWestrienen, and Marc DeJohn in 2012.

Total Funding Amount:

$1.42M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2012-01-01

Contact Email:

max(AT)bio-meme.com

Founders:

Jesse vanWestrienen, Marc DeJohn, Max Perelman

Number of Employees:

1-10

Last Funding Date:

2024-03-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai